Just days after a promising run in Washington, Emma Raducanu’s 2026 hard-court summer has come to a screeching halt. On August 1, her management team confirmed the 23-year-old has withdrawn from the US Open, scheduled to begin August 24 at Flushing Meadows, due to a stress fracture in her right foot. The diagnosis - a hairline break in the second metatarsal - came after she reported discomfort following her semifinal loss at the Mubadala Citi DC Open. For a player who has battled recurring physical setbacks, this news hits hard for British tennis fans hoping for a deep New York run.
The Injury: A Preventative Call, Not a Crisis
The fracture was diagnosed in London on July 31, just one day before the official withdrawal announcement. Raducanu felt pain as early as the third game of her Washington semifinal against Paula Badosa (a 6-3, 7-5 loss on August 2), but gutted through the match before seeking immediate medical attention. Her team’s statement was blunt: "Emma has been advised to rest and undergo a period of non-weight-bearing rehabilitation. She will not be fit for the US Open."
Coach Nick Cavaday, speaking to BBC Sport on August 3, framed the decision as long-term thinking over short-term gain. "This is a preventative measure. The fracture is hairline, but with her history of recurring injuries, we are not risking it," he said. Notably, this is a fresh overuse injury - unrelated to the wrist and ankle surgeries that sidelined her between 2023 and 2025. The six-to-eight-week recovery protocol targets a return at the Pan Pacific Open in Tokyo (September 21 - 27) or the China Open in Beijing (October 1 - 8).
📊 Hairline fracture, not surgery - This is a new overuse injury in the second metatarsal, completely unrelated to her previous wrist and ankle procedures.
Ranking Drop and Financial Hit: The Cost of Staying Home
Raducanu's absence from New York carries immediate consequences beyond the physical rehab. Currently ranked World No. 42, she will tumble to approximately No. 58 after the tournament, because she cannot defend the 430 points earned from her 2025 US Open quarterfinal run. That’s a significant slide that could affect her seeding at upcoming WTA 1000 events and Grand Slams next season.
Financially, the withdrawal is also a gut punch. Raducanu forfeits the guaranteed $100,000 first-round prize money for the 2026 US Open singles draw - money she would have earned simply by stepping on court. Meanwhile, the USTA has already reallocated her main-draw slot to a lucky loser from qualifying, meaning her ranking protection does not apply for this event. On the sponsorship front, both Nike and Wilson released joint statements on August 2 confirming zero contract changes, though all promotional appearances for Raducanu are paused through the end of August. Stability off the court, but silence on it.
| Metric | Value |
|---|---|
| Current Ranking (July 27, 2026) | World No. 42 |
| Projected Ranking Post-US Open | Approximately No. 58 |
| Points Unable to Defend | 430 (2025 quarterfinal run) |
| Forfeited First-Round Prize Money | $100,000 |
| Projected Return Window | 6-8 weeks (late September) |
Rehabilitation Roadmap: Tokyo or Beijing for a Return?
The next eight weeks will be critical for Raducanu’s recovery. Her medical team has prescribed a strict non-weight-bearing protocol for the foot, which means significant time off court. The goal is straightforward: heal the second metatarsal fully before returning to the grind of the WTA tour. The projected timeline puts her back in action in late September, making the Pan Pacific Open in Tokyo the earliest viable target. Beijing, with its 1000-level points, might be the smarter play if any lingering soreness persists.
